Semi-synthetic cannabinoid derivative drug
Pharmaceutical compound
HHCP-O-acetate (HHCPO, HHCP-O) is a semi-synthetic derivative of tetrahydrocannabiphorol (THCP) derived in several steps by hydrogenation to hexahydrocannabiphorol (HHCP) followed by acetylation of the OH group. It has been found as a component of grey-market cannabis products such as e-cigarette liquids and edible gumdrops, and is allegedly a potent and long-lasting psychoactive cannabinoid.[1]
Confusion about acronym
Some vendors have mistakenly claimed that HHCPO stands for hexahydrocannabinol propionate (HHC-P) or hexahydrocannabinol cyclopropyl ether, but these are different compounds.
Hexahydrocannabinol propionate (left) and Hexahydrocannabinol cyclopropyl ether (right)
See also
References
- ^ Erickson BE (2023). “Waiting for CBD regulations in the US”. Chemical & Engineering News. 101 (28): 17–19. doi:10.1021/cen-10128-feature1. S2CID 261318144.